Global Androgen Deprivation Therapy (ADT) Market Research Report Forecast 2017-2022

July 2017 | 120 pages | ID: GC48B6F2A85EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Global Androgen Deprivation Therapy (ADT) Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Androgen Deprivation Therapy (ADT) industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Androgen Deprivation Therapy (ADT) market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Global Androgen Deprivation Therapy (ADT) Market: Regional Segment Analysis

North America
Europe
China
Japan
Southeast Asia
India

The Major players reported in the market include:

Pfizer Inc. (USA)
Abbott Laboratories (USA)
Genentech Inc. (USA)
GlaxoSmithKline Plc (UK)
Immunomedics, Inc. (USA)
Indevus Pharmaceuticals Inc. (USA)
Novartis AG (Switzerland)
OSI Pharmaceuticals, Inc. (USA)
Paladin Labs Inc. (Canada)

Global Androgen Deprivation Therapy (ADT) Market: Product Segment Analysis

• Type 1
• Type 2
• Type 3

Global Androgen Deprivation Therapy (ADT) Market: Application Segment Analysis

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 ANDROGEN DEPRIVATION THERAPY (ADT) MARKET OVERVIEW

1.1 Product Overview and Scope of Androgen Deprivation Therapy (ADT)
1.2 Androgen Deprivation Therapy (ADT) Market Segmentation by Type
  1.2.1 Global Production Market Share of Androgen Deprivation Therapy (ADT) by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Androgen Deprivation Therapy (ADT) Market Segmentation by Application
  1.3.1 Androgen Deprivation Therapy (ADT) Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Androgen Deprivation Therapy (ADT) Market Segmentation by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India
1.5 Global Market Size (Value) of Androgen Deprivation Therapy (ADT) (2012-2022)

CHAPTER 2 GLOBAL ECONOMIC IMPACT ON ANDROGEN DEPRIVATION THERAPY (ADT) INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

CHAPTER 3 GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET COMPETITION BY MANUFACTURERS

3.1 Global Androgen Deprivation Therapy (ADT) Production and Share by Manufacturers (2015 and 2016)
3.2 Global Androgen Deprivation Therapy (ADT) Revenue and Share by Manufacturers (2015 and 2016)
3.3 Global Androgen Deprivation Therapy (ADT) Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Androgen Deprivation Therapy (ADT) Manufacturing Base Distribution, Production Area and Product Type
3.5 Androgen Deprivation Therapy (ADT) Market Competitive Situation and Trends
  3.5.1 Androgen Deprivation Therapy (ADT) Market Concentration Rate
  3.5.2 Androgen Deprivation Therapy (ADT) Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

4.1 Global Androgen Deprivation Therapy (ADT) Production by Region (2012-2017)
4.2 Global Androgen Deprivation Therapy (ADT) Production Market Share by Region (2012-2017)
4.3 Global Androgen Deprivation Therapy (ADT) Revenue (Value) and Market Share by Region (2012-2017)
4.4 Global Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
4.5 North America Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
4.6 Europe Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
4.7 China Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
4.8 Japan Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
4.9 Southeast Asia Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
4.10 India Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)

CHAPTER 5 GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

5.1 Global Androgen Deprivation Therapy (ADT) Consumption by Regions (2012-2017)
5.2 North America Androgen Deprivation Therapy (ADT) Production, Consumption, Export, Import by Regions (2012-2017)
5.3 Europe Androgen Deprivation Therapy (ADT) Production, Consumption, Export, Import by Regions (2012-2017)
5.4 China Androgen Deprivation Therapy (ADT) Production, Consumption, Export, Import by Regions (2012-2017)
5.5 Japan Androgen Deprivation Therapy (ADT) Production, Consumption, Export, Import by Regions (2012-2017)
5.6 Southeast Asia Androgen Deprivation Therapy (ADT) Production, Consumption, Export, Import by Regions (2012-2017)
5.7 India Androgen Deprivation Therapy (ADT) Production, Consumption, Export, Import by Regions (2012-2017)

CHAPTER 6 GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

6.1 Global Androgen Deprivation Therapy (ADT) Production and Market Share by Type (2012-2017)
6.2 Global Androgen Deprivation Therapy (ADT) Revenue and Market Share by Type (2012-2017)
6.3 Global Androgen Deprivation Therapy (ADT) Price by Type (2012-2017)
6.4 Global Androgen Deprivation Therapy (ADT) Production Growth by Type (2012-2017)

CHAPTER 7 GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ANALYSIS BY APPLICATION

7.1 Global Androgen Deprivation Therapy (ADT) Consumption and Market Share by Application (2012-2017)
7.2 Global Androgen Deprivation Therapy (ADT) Consumption Growth Rate by Application (2012-2017)
7.3 Market Drivers and Opportunities
  7.3.1 Potential Applications
  7.3.2 Emerging Markets/Countries

CHAPTER 8 GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MANUFACTURERS ANALYSIS

8.1 Pfizer Inc. (USA)
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Type, Application and Specification
  8.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 Abbott Laboratories (USA)
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Type, Application and Specification
  8.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 Genentech Inc. (USA)
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Type, Application and Specification
  8.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 GlaxoSmithKline Plc (UK)
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Type, Application and Specification
  8.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 Immunomedics, Inc. (USA)
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Type, Application and Specification
  8.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 Indevus Pharmaceuticals Inc. (USA)
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Type, Application and Specification
  8.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 Novartis AG (Switzerland)
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Type, Application and Specification
  8.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 OSI Pharmaceuticals, Inc. (USA)
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Type, Application and Specification
  8.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 Paladin Labs Inc. (Canada)
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Type, Application and Specification
  8.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview

CHAPTER 9 ANDROGEN DEPRIVATION THERAPY (ADT) MANUFACTURING COST ANALYSIS

9.1 Androgen Deprivation Therapy (ADT) Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Androgen Deprivation Therapy (ADT)

CHAPTER 10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Androgen Deprivation Therapy (ADT) Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Androgen Deprivation Therapy (ADT) Major Manufacturers in 2016
10.4 Downstream Buyers

CHAPTER 11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

CHAPTER 12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

CHAPTER 13 GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET FORECAST (2017-2022)

13.1 Global Androgen Deprivation Therapy (ADT) Production, Revenue Forecast (2017-2022)
13.2 Global Androgen Deprivation Therapy (ADT) Production, Consumption Forecast by Regions (2017-2022)
13.3 Global Androgen Deprivation Therapy (ADT) Production Forecast by Type (2017-2022)
13.4 Global Androgen Deprivation Therapy (ADT) Consumption Forecast by Application (2017-2022)
13.5 Androgen Deprivation Therapy (ADT) Price Forecast (2017-2022)

CHAPTER 14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Androgen Deprivation Therapy (ADT)
Figure Global Production Market Share of Androgen Deprivation Therapy (ADT) by Type in 2016
Table Androgen Deprivation Therapy (ADT) Consumption Market Share by Application in 2016
Figure North America Androgen Deprivation Therapy (ADT) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Androgen Deprivation Therapy (ADT) Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Androgen Deprivation Therapy (ADT) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Androgen Deprivation Therapy (ADT) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Androgen Deprivation Therapy (ADT) Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Androgen Deprivation Therapy (ADT) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Androgen Deprivation Therapy (ADT) Revenue (Million UDS) and Growth Rate (2012-2022)
Table Global Androgen Deprivation Therapy (ADT) Capacity of Key Manufacturers (2015 and 2016)
Table Global Androgen Deprivation Therapy (ADT) Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Androgen Deprivation Therapy (ADT) Capacity of Key Manufacturers in 2015
Figure Global Androgen Deprivation Therapy (ADT) Capacity of Key Manufacturers in 2016
Table Global Androgen Deprivation Therapy (ADT) Production of Key Manufacturers (2015 and 2016)
Table Global Androgen Deprivation Therapy (ADT) Production Share by Manufacturers (2015 and 2016)
Figure 2015 Androgen Deprivation Therapy (ADT) Production Share by Manufacturers
Figure 2016 Androgen Deprivation Therapy (ADT) Production Share by Manufacturers
Table Global Androgen Deprivation Therapy (ADT) Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Androgen Deprivation Therapy (ADT) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Androgen Deprivation Therapy (ADT) Revenue Share by Manufacturers
Table 2016 Global Androgen Deprivation Therapy (ADT) Revenue Share by Manufacturers
Table Global Market Androgen Deprivation Therapy (ADT) Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Androgen Deprivation Therapy (ADT) Average Price of Key Manufacturers in 2016
Table Manufacturers Androgen Deprivation Therapy (ADT) Manufacturing Base Distribution and Sales Area
Table Manufacturers Androgen Deprivation Therapy (ADT) Product Type
Figure Androgen Deprivation Therapy (ADT) Market Share of Top 3 Manufacturers
Figure Androgen Deprivation Therapy (ADT) Market Share of Top 5 Manufacturers
Table Global Androgen Deprivation Therapy (ADT) Capacity by Regions (2012-2017)
Figure Global Androgen Deprivation Therapy (ADT) Capacity Market Share by Regions (2012-2017)
Figure Global Androgen Deprivation Therapy (ADT) Capacity Market Share by Regions (2012-2017)
Figure 2015 Global Androgen Deprivation Therapy (ADT) Capacity Market Share by Regions
Table Global Androgen Deprivation Therapy (ADT) Production by Regions (2012-2017)
Figure Global Androgen Deprivation Therapy (ADT) Production and Market Share by Regions (2012-2017)
Figure Global Androgen Deprivation Therapy (ADT) Production Market Share by Regions (2012-2017)
Figure 2015 Global Androgen Deprivation Therapy (ADT) Production Market Share by Regions
Table Global Androgen Deprivation Therapy (ADT) Revenue by Regions (2012-2017)
Table Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Regions (2012-2017)
Table 2015 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Regions
Table Global Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table North America Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table China Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table India Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Androgen Deprivation Therapy (ADT) Consumption Market by Regions (2012-2017)
Table Global Androgen Deprivation Therapy (ADT) Consumption Market Share by Regions (2012-2017)
Figure Global Androgen Deprivation Therapy (ADT) Consumption Market Share by Regions (2012-2017)
Figure 2015 Global Androgen Deprivation Therapy (ADT) Consumption Market Share by Regions
Table North America Androgen Deprivation Therapy (ADT) Production, Consumption, Import & Export (2012-2017)
Table Europe Androgen Deprivation Therapy (ADT) Production, Consumption, Import & Export (2012-2017)
Table China Androgen Deprivation Therapy (ADT) Production, Consumption, Import & Export (2012-2017)
Table Japan Androgen Deprivation Therapy (ADT) Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia Androgen Deprivation Therapy (ADT) Production, Consumption, Import & Export (2012-2017)
Table India Androgen Deprivation Therapy (ADT) Production, Consumption, Import & Export (2012-2017)
Table Global Androgen Deprivation Therapy (ADT) Production by Type (2012-2017)
Table Global Androgen Deprivation Therapy (ADT) Production Share by Type (2012-2017)
Figure Production Market Share of Androgen Deprivation Therapy (ADT) by Type (2012-2017)
Figure 2015 Production Market Share of Androgen Deprivation Therapy (ADT) by Type
Table Global Androgen Deprivation Therapy (ADT) Revenue by Type (2012-2017)
Table Global Androgen Deprivation Therapy (ADT) Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Androgen Deprivation Therapy (ADT) by Type (2012-2017)
Figure 2015 Revenue Market Share of Androgen Deprivation Therapy (ADT) by Type
Table Global Androgen Deprivation Therapy (ADT) Price by Type (2012-2017)
Figure Global Androgen Deprivation Therapy (ADT) Production Growth by Type (2012-2017)
Table Global Androgen Deprivation Therapy (ADT) Consumption by Application (2012-2017)
Table Global Androgen Deprivation Therapy (ADT) Consumption Market Share by Application (2012-2017)
Figure Global Androgen Deprivation Therapy (ADT) Consumption Market Share by Application in 2015
Table Global Androgen Deprivation Therapy (ADT) Consumption Growth Rate by Application (2012-2017)
Figure Global Androgen Deprivation Therapy (ADT) Consumption Growth Rate by Application (2012-2017)
Table Pfizer Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Inc. (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Inc. (USA) Androgen Deprivation Therapy (ADT) Market Share (2012-2017)
Table Abbott Laboratories (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Abbott Laboratories (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories (USA) Androgen Deprivation Therapy (ADT) Market Share (2012-2017)
Table Genentech Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Genentech Inc. (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table Genentech Inc. (USA) Androgen Deprivation Therapy (ADT) Market Share (2012-2017)
Table GlaxoSmithKline Plc (UK) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Plc (UK) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Plc (UK) Androgen Deprivation Therapy (ADT) Market Share (2012-2017)
Table Immunomedics, Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Immunomedics, Inc. (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table Immunomedics, Inc. (USA) Androgen Deprivation Therapy (ADT) Market Share (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Indevus Pharmaceuticals Inc. (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Androgen Deprivation Therapy (ADT) Market Share (2012-2017)
Table Novartis AG (Switzerland) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis AG (Switzerland) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis AG (Switzerland) Androgen Deprivation Therapy (ADT) Market Share (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table OSI Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Market Share (2012-2017)
Table Paladin Labs Inc. (Canada) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Paladin Labs Inc. (Canada) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table Paladin Labs Inc. (Canada) Androgen Deprivation Therapy (ADT) Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Androgen Deprivation Therapy (ADT)
Figure Manufacturing Process Analysis of Androgen Deprivation Therapy (ADT)
Figure Androgen Deprivation Therapy (ADT) Industrial Chain Analysis
Table Raw Materials Sources of Androgen Deprivation Therapy (ADT) Major Manufacturers in 2016
Table Major Buyers of Androgen Deprivation Therapy (ADT)
Table Distributors/Traders List
Figure Global Androgen Deprivation Therapy (ADT) Production and Growth Rate Forecast (2017-2022)
Figure Global Androgen Deprivation Therapy (ADT) Revenue and Growth Rate Forecast (2017-2022)
Table Global Androgen Deprivation Therapy (ADT) Production Forecast by Regions (2017-2022)
Table Global Androgen Deprivation Therapy (ADT) Consumption Forecast by Regions (2017-2022)
Table Global Androgen Deprivation Therapy (ADT) Production Forecast by Type (2017-2022)
Table Global Androgen Deprivation Therapy (ADT) Consumption Forecast by Application (2017-2022)